The QRS narrowing index predicts reverse left ventricular remodeling following cardiac resynchronization therapy

PACE - Pacing and Clinical Electrophysiology

Volumn 34, Issue 5, 2011, Pages 604-611

  Rickard, John ^a   Popovic, Zoran ^a   Verhaert, David ^a   Sraow, Dan ^a   Baranowski, Bryan ^a   Martin, David O ^a   Lindsay, Bruce D ^a   Varma, Niraj ^a   Tchou, Patrick ^a   Grimm, Richard A ^a   Wilkoff, Bruce L ^a   Chung, Mina K ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Congestive heart failure; CRT; Electrophysiology clinical

Indexed keywords

ANTIARRHYTHMIC AGENT; NITRATE;

ADULT; AGED; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CARDIAC RESYNCHRONIZATION THERAPY DEVICE; DISEASE CLASSIFICATION; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; FEMALE; HEART FAILURE; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HEART VENTRICLE CONDUCTION; HUMAN; IMAGE ANALYSIS; IMPLANTATION; MALE; MEDICAL RECORD REVIEW; NONISCHEMIC CARDIOMYOPATHY; PREDICTIVE VALUE; QRS COMPLEX; QRS NARROWING; RETROSPECTIVE STUDY; REVERSE HEART LEFT VENTRICLE REMODELING; SEX DIFFERENCE; TREATMENT RESPONSE;

ARRHYTHMIAS, CARDIAC; BIOLOGICAL MARKERS; CARDIAC RESYNCHRONIZATION THERAPY; CHI-SQUARE DISTRIBUTION; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; HEART FAILURE; HUMANS; LOGISTIC MODELS; MALE; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; STROKE VOLUME; VENTRICULAR REMODELING;

EID: 79957542418     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2010.03022.x     Document Type: Article

References (26)

1. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, DeMarco T, Carson P, et al. Cardiac resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004; 350:2140-2150.
2. Abraham WT, Fisher WG, Smith AL, Delurgio DB, Leon AR, Loh E, Kocovic DZ, et al. Cardiac-resynchronization in chronic heart failure. N Engl J Med 2002; 346:1845-1853.
3. Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, Tavazzi L; Cardiac resynchronization-Heart Failure Investigators. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005; 352:1539-1549. (Pubitemid 40517094)
4. Bax JJ, Ansalone G, Breithardt OA, Derumeaux G, Leclercq C, Schalij MJ, Sogaard P, et al. Echocardiographic evaluation of cardiac resynchronization therapy: Ready for routine clinical use? A critical appraisal. J Am Coll Cardiol 2004; 44:1-9. (Pubitemid 38968446)
5. Bax JJ, Bleeker GB,Marwick TH, Molhoek SG, Boersma E, Steendijk P, Van Der Wall EE, et al. Left ventricular dyssynchrony predicts response and prognosis after cardiac resynchronization therapy. J Am Coll Cardiol 2004; 44:1834-1840. (Pubitemid 39424084)
6. Leclercq C, Faris O, Tunin R, Johnson J, Kato R, Evans F, Spinelli J, et al. Systolic improvement and mechanical resynchronization does not require electrical synchrony in the dilated failing heart with left- bundle branch block. Circulation 2002; 106:1760-1763.
7. Reuter S, Garrigue S, Bordachar P, Hocini M, Jais P, Haissaguerre M, Clementy J. Intermediate-term results of biventricular pacing in heart failure: Correlation between clinical and hemodynamic data. Pacing Clin Electrophysiol 2000; 23:1713-1717.
8. Alonso C, Leclercq C, Victor F, Mansour H, de Place C, Pavin D, Carre F, et al. Electrocardiographic predictive factors of longterm clinical improvement with multisite biventricular pacing in advanced heart failure. Am J Cardiol 1999; 84:1417-1421.
9. Molhoek SG, Van Erven L, Bootsma M, Steendijk P, Van Der Wall EE, Schalij MJ. QRS duration and shortening to predict clinical response to cardiac resynchronization therapy in patients with end-stage heart failure. Pacing Clin Electrophysiol 2004; 27:308-313. (Pubitemid 38352508)
10. Lecoq G, Leclerq C, Leray E, Crocq C, Alonso C, de Place C, Mabo P, et al. Clinical and electrocardiographic predictors of a positive response to cardiac resynchronization therapy in advanced heart failure. Eur Heart J 2005; 26:1094-1100. (Pubitemid 40839910)
11. Iler MA, Hu T, Ayyagari S, Callahan TD 4th, Civello KC, Thal SG, Wilkoff BL, et al. Prognostic value of electrocardiographic measurements before and after cardiac resynchronization device implantation in patients with heart failure due to ischemic or nonischemic cardiomyopathy. Am J Cardiol 2008; 101:359-363. (Pubitemid 351162967)
12. Wilton SB, Shibata MA, Sondergaard R, Cowan K, Semeniuk L, Exner DV. Relationship between left ventricular lead position using a simple radiographic classification scheme and long-term outcome with resynchronization therapy. J Interv Card Electrophysiol 2008; 23:219-227.
13. Mullens W, Grimm RA, Verga T, Dresing T, Starling RC, Wilkoff BL, Tang WH. Insights from a cardiac resynchronization optimization clinic as part of a heart failure disease management program. J Am Coll Cardiol 2009; 53:765-773.
14. Iuliano S, Fisher SG, Karasik PE, Fletcher RD, Singh SN. QRS duration and mortality in patients with congestive heart failure. Am Heart J 2002; 143:1085-1091. (Pubitemid 34666902)
15. Shamim W, Francis DP, Yousufuddin M, Varney S, Pieopli MF, Anker SD, Coats AJ. Intraventricular conduction delay:Aprognostic marker in chronic heart failure. Int J Cardiol 1999; 70:171-178. (Pubitemid 29354368)
16. Bleeker GB, Schalij MJ, Molhoek SG, Verwey HF, Holman ER, Boersma E, Steendijk P, et al. Relationship between QRS duration and left ventricular dyssynchrony in patients with end-stage heart failure. J Cardiovasc Electrophysiol 2004; 14:544-549. (Pubitemid 38621905)
17. Mollema SA, Bleeker GB, Van Der Wall EE, Schalij MJ, Bax JJ. Usefulness of QRS duration to predict response to cardiac resynchronization therapy in patients with end-stage heart failure. Am J Cardiol 2007; 100:1665-1670. (Pubitemid 350123732)
18. Sandhu R, Bahler RC. Prevalence of QRS prolongation in a community hospital cohort of patients with heart failure and its relation to left ventricular dysfunction. Am J Cardiol 2004; 93:244-246. (Pubitemid 38058744)
19. Kashani A, Barold SS. Significance of QRS complex duration in patients with heart failure. J Am Coll Cardiol 2005; 46:2183-2192. (Pubitemid 41785483)
20. Boriani G, Biffi M, Martignani C, Valzania C, Diemberger I, Ziacchi M, Artale P, et al. Electrocardiographic remodeling during cardiac resynchronization therapy. Int J Cardiol 2006; 108:165-170. (Pubitemid 43330608)
21. Yu CM, Chan YS, Zhang Q, Yip GW, Chan CK, Kum LC, Wu L, et al. Benefits of cardiac resynchronization therapy for heart failure patients with narrow QRS complexes and coexisting systolic asynchrony by echocardiography. J Am Coll Cardiol 2006; 48:2251-2257. (Pubitemid 44873057)
22. Rickard J, Sraow D, Baranowski B, Martin DO, GrimM RA, Wilkoff BL, Chung MK. QRS changes in heart failure patients undergoing cardiac resynchronization therapy with non-LBBB morphologies. (Abstract) OHIO ACC, Colombus Ohio, 10/2009.
23. Rickard J, Kumbhani DJ, Gorodeski EZ, Baranowski B, Wazni O, Martin DO, Grimm RA, et al. Cardiac resynchronization therapy in non-left bundle branch block morphologies. Pacing Clin Electrophysiol 2010; 33:590-595.
24. Adelstein EC, Saba S. Usefulness of baseline electrocardiographic QRS complex pattern to predict response to cardiac resynchronization. Am J Cardiol 2009; 103:238-242.
25. Chung ES, Leon AR, Tavazzi L, Sun JP, Nihoyannopoulos P, Merlino J, Abraham WT, et al. Results of the predictors of response (PROSPECT) trial. Circulation 2008; 117:2567-2569.
26. Moss AJ, Hall WJ, Cannom DS, Klein H, Brown MW, Daubert JP, Estes NA 3rd, et al. Cardiac-resynchronization therapy for the prevention of heart-failure events. N Engl J Med 2009; 361:1329-1338.